|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.24/4.86
|
企业价值
24.53B
|
资产负债 |
每股账面净值
-3.04
|
现金流量 |
现金流量率
0.42
|
损益表 |
收益
8.76B
|
每股收益
23.29
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/19 00:47 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |